Literature DB >> 24676360

Expression analysis of serum microRNAs in idiopathic pulmonary fibrosis.

Ping Li1, Juan Li1, Tengfei Chen1, Huaqi Wang1, Heying Chu1, Jingxia Chang1, Wenqiao Zang2, Yuanyuan Wang2, Yunyun Ma2, Yuwen Du2, Guoqiang Zhao2, Guojun Zhang1.   

Abstract

Idiopathic pulmonary fibrosis (IPF) is a disease of unknown etiology with considerable morbidity and mortality. Seeking informative diagnostic markers with greater clinical significance is essential for the early diagnosis of IPF. microRNAs (miRNAs or miRs) have emerged as novel serum diagnostic biomarkers for various diseases. In this study, we performed microarray analysis of the miRNA expression profile in the serum of patients with IPF compared to that of control subjects. We then performed a preliminary analysis of biological functions for the most differentially expressed miRNAs. Some of the microarray results were validated by quantitative reverse transcription-polymerase chain reaction (qRT-PCR). The results from this study provide evidence to link the biological role of miRNAs to IPF, and suggest that miRNAs may undertake a variety of functions. Additionally, we found that the altered expression levels of miR-21, miR-155 and miR-101-3p were associated with forced vital capacity (FVC) and radiological features in IPF. Our data may serve as a basis for further investigation, preferably in large prospective studies, before miRNA can be used as a non-invasive screening tool for IPF in routine clinical practice.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24676360     DOI: 10.3892/ijmm.2014.1712

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  27 in total

1.  MicroRNA-215 Regulates Fibroblast Function: Insights from a Human Fibrotic Disease.

Authors:  Wanwen Lan; Silin Chen; Louis Tong
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

2.  Upregulated has-miR-4516 as a potential biomarker for early diagnosis of dust-induced pulmonary fibrosis in patients with pneumoconiosis.

Authors:  Ruixue Huang; Ting Yu; Ying Li; Jianan Hu
Journal:  Toxicol Res (Camb)       Date:  2018-02-08       Impact factor: 3.524

Review 3.  The role of microRNAs in chronic respiratory disease: recent insights.

Authors:  Lindsay R Stolzenburg; Ann Harris
Journal:  Biol Chem       Date:  2018-02-23       Impact factor: 3.915

Review 4.  MicroRNAs in non-small cell lung cancer and idiopathic pulmonary fibrosis.

Authors:  Keiko Mizuno; Hiroko Mataki; Naohiko Seki; Tomohiro Kumamoto; Kazuto Kamikawaji; Hiromasa Inoue
Journal:  J Hum Genet       Date:  2016-08-04       Impact factor: 3.172

Review 5.  Clinical value of non-coding RNAs in cardiovascular, pulmonary, and muscle diseases.

Authors:  Sébastien Bonnet; Olivier Boucherat; Roxane Paulin; Danchen Wu; Charles C T Hindmarch; Stephen L Archer; Rui Song; Joseph B Moore; Steeve Provencher; Lubo Zhang; Shizuka Uchida
Journal:  Am J Physiol Cell Physiol       Date:  2019-09-04       Impact factor: 4.249

Review 6.  Epigenetic targets for novel therapies of lung diseases.

Authors:  Brian S Comer; Mariam Ba; Cherie A Singer; William T Gerthoffer
Journal:  Pharmacol Ther       Date:  2014-11-15       Impact factor: 12.310

Review 7.  The code of non-coding RNAs in lung fibrosis.

Authors:  Huachun Cui; Na Xie; Victor J Thannickal; Gang Liu
Journal:  Cell Mol Life Sci       Date:  2015-05-31       Impact factor: 9.261

8.  miR-184 targets TP63 to block idiopathic pulmonary fibrosis by inhibiting proliferation and epithelial-mesenchymal transition of airway epithelial cells.

Authors:  Jianmin Li; Chanyuan Pan; Chao Tang; Wenwen Tan; Weiwei Zhang; Jing Guan
Journal:  Lab Invest       Date:  2020-09-28       Impact factor: 5.662

Review 9.  Diagnostic Potential of Extracellular MicroRNA in Respiratory Diseases.

Authors:  Dhamotharan Pattarayan; Rajesh K Thimmulappa; Vilwanathan Ravikumar; Subbiah Rajasekaran
Journal:  Clin Rev Allergy Immunol       Date:  2018-06       Impact factor: 8.667

Review 10.  Decrypting the crosstalk of noncoding RNAs in the progression of IPF.

Authors:  Yujuan Wang; Han Xiao; Fenglian Zhao; Han Li; Rong Gao; Bingdi Yan; Jin Ren; Junling Yang
Journal:  Mol Biol Rep       Date:  2020-03-16       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.